Basics Gossamer Bio, Inc. IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $770.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.58% Avg Daily Range (30 D): $0.10 | 3.61% Avg Daily Range (90 D): $0.10 | 3.96% Institutional Daily Volume Avg Daily Volume: 1.21M Avg Daily Volume (30 D): 2.64M Avg Daily Volume (90 D): 3.22M Trade Size Avg Trade Size (Sh.): 179 Avg Trade Size (Sh.) (30 D): 199 Avg Trade Size (Sh.) (90 D): 231 Institutional Trades Total Inst.Trades: 1,291 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $.77M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $.83M Avg Closing Trade (90 D): $1.01M Avg Closing Volume: 328.87K     News Sep 25, 2025 @ 11:41 AM Respira Therapeutics Enters into Agreement with Go... Source: Prnewswire Sep 25, 2025 @ 11:31 AM Gossamer Bio Enters into Option Agreement to Acqui... Source: Business Wire Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.69 $-.21 $-.17 Diluted EPS $-.69 $-.21 $-.17 Revenue $ 44.05M $ 13.29M $ 11.49M Gross Profit $ $ $ Net Income / Loss $ -156.16M $ -48.22M $ -38.27M Operating Income / Loss $ -160.82M $ -49.11M $ -38.77M Cost of Revenue $ $ $ Net Cash Flow $ -19.55M $ -17.28M $ -2.84M PE Ratio